Conversely, disruption of nocturnal melatonin driven by light-at-night in a model of MCF-7 cancer xenografts grown in nude rats induces doxorubicin resistance that involves inhibition of phospho-AKT activation. The gene discussed is AKT1; the disease is cancer.